AngioDynamics Q4 revenue rises 8% to $86.6 million as Med Tech jumps 16.7%

H.C. Wainwright lifted its price target to $19 from $16 and kept a Buy rating after strength in NanoKnife and AlphaVac helped drive quarterly growth.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.